Ptpn2 knockdown likely increases melanoma cell sensitivity to IFNγ by enhancing STAT1, STAT3, and STAT5 phosphorylation and MHC-I, MHC-II, and PD-L1 expression (61, 62). The gene discussed is PTPN2; the disease is melanoma.